1 November 2024 false No description of principal activity Taxfiler 2024.6 09821814 business:PrivateLimitedCompanyLtd 2024-11-01 2025-10-31 09821814 2024-10-31 09821814 2024-11-01 2025-10-31 09821814 business:AuditExempt-NoAccountantsReport 2024-11-01 2025-10-31 09821814 business:FilletedAccounts 2024-11-01 2025-10-31 09821814 2025-10-31 09821814 business:Director1 2024-11-01 2025-10-31 09821814 business:RegisteredOffice 2024-11-01 2025-10-31 09821814 2024-10-31 09821814 core:WithinOneYear 2025-10-31 09821814 core:WithinOneYear 2024-10-31 09821814 core:SharePremium core:PreviouslyStatedAmount 2025-10-31 09821814 core:SharePremium core:PreviouslyStatedAmount 2024-10-31 09821814 core:RetainedEarningsAccumulatedLosses core:PreviouslyStatedAmount 2025-10-31 09821814 core:RetainedEarningsAccumulatedLosses core:PreviouslyStatedAmount 2024-10-31 09821814 core:PreviouslyStatedAmount 2025-10-31 09821814 core:PreviouslyStatedAmount 2024-10-31 09821814 business:SmallEntities 2024-11-01 2025-10-31 09821814 countries:EnglandWales 2024-11-01 2025-10-31 09821814 core:MotorVehicles 2024-10-31 09821814 core:MotorVehicles 2025-10-31 09821814 core:MotorVehicles 2024-11-01 2025-10-31 09821814 2023-11-01 2024-10-31 iso4217:GBP xbrli:pure
Company Registration No. 09821814 (England and Wales)
AA PHARMACARE LTD Unaudited accounts for the year ended 31 October 2025
AA PHARMACARE LTD Unaudited accounts Contents
Page
Company information
3
Statement of financial position
4
Notes to the accounts
5
- 2 -
AA PHARMACARE LTD Company Information for the year ended 31 October 2025
Director
AMINA BINT ABDUL-MALIK
Company Number
09821814 (England and Wales)
Registered Office
156 WRICKELEMARSH ROAD BLACKHEATH LONDON SE3 8DP ENGLAND
- 3 -
AA PHARMACARE LTD Statement of financial position as at 31 October 2025
2025
2024
Notes
£
£
Fixed assets
Tangible assets
4
1,008
1,259
Current assets
Cash at bank and in hand
27,945
45,857
Creditors: amounts falling due within one year
5
(23,466)
(42,842)
Net current assets
4,479
3,015
Net assets
5,487
4,274
Capital and reserves
Share premium
100
100
Profit and loss account
5,387
4,174
Shareholders' funds
5,487
4,274
For the year ending 31 October 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 22 July 2026 and were signed on its behalf by
AMINA BINT ABDUL-MALIK Director Company Registration No. 09821814
- 4 -
AA PHARMACARE LTD Notes to the Accounts for the year ended 31 October 2025
1
Statutory information
AA PHARMACARE LTD is a private company, limited by shares, registered in England and Wales, registration number 09821814. The registered office is 156 WRICKELEMARSH ROAD, BLACKHEATH, LONDON, SE3 8DP, ENGLAND.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
4
Tangible fixed assets
Motor vehicles
£
Cost or valuation
At cost
At 1 November 2024
5,994
At 31 October 2025
5,994
Depreciation
At 1 November 2024
4,735
Charge for the year
251
At 31 October 2025
4,986
Net book value
At 31 October 2025
1,008
At 31 October 2024
1,259
5
Creditors: amounts falling due within one year
2025
2024
£
£
Taxes and social security
433
1,728
Proposed dividends
-
29,412
Loans from directors
7,270
3,172
Accruals
15,763
8,530
23,466
42,842
- 5 -
AA PHARMACARE LTD Notes to the Accounts for the year ended 31 October 2025
6
Average number of employees
During the year the average number of employees was 1 (2024: 1).
- 6 -